Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis delta virus pathogenicity

E J Gowans1, F Bonino

  • 1Division of Medical Virology, Institute of Medical and Veterinary Science, Adelaide, Australia.

Progress in Clinical and Biological Research
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of a mixed-linker Ce-UiO-67 metal-organic framework.

RSC applied interfaces·2024
Same author

ANN uncertainty estimates in assessing fatty liver content from ultrasound data.

Computational and structural biotechnology journal·2024
Same author

NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.

Science advances·2019
Same author

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery.

Scientific reports·2019
Same author

Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes.

Vaccine·2019
Same author

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

Scientific reports·2018
Same journal

DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.

Progress in clinical and biological research·2018
Same journal

Endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance, and therapy. Proceedings of the 4th Conference of the International Endotoxin Society. Nagoya, Japan, October 23-27, 1996.

Progress in clinical and biological research·1998
Same journal

The pathogenic role of LBP in gram-negative sepsis and septic shock.

Progress in clinical and biological research·1998
Same journal

The role of interleukin 6 in endotoxin-induced inflammatory responses.

Progress in clinical and biological research·1998
Same journal

Role of nitric oxide and reactive oxygen species in endotoxin shock.

Progress in clinical and biological research·1998
Same journal

Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.

Progress in clinical and biological research·1998
See all related articles

Hepatitis Delta Virus (HDV) infection can be directly harmful to the liver or not, depending on the infection stage. Different HDV strains and Hepatitis B Virus (HBV) interactions may influence disease severity.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis Delta Virus (HDV) is a significant cause of liver disease, often occurring in individuals with Hepatitis B Virus (HBV) infection.
  • The precise mechanisms by which HDV causes liver damage and the role of HBV in this process are not fully understood.

Purpose of the Study:

  • To review and synthesize current data on the pathogenetic mechanisms of HDV infection.
  • To explore the potential for HDV to be directly cytopathic or non-cytopathic.
  • To investigate the influence of HBV replication and variants on HDV pathogenicity.

Main Methods:

  • This review synthesizes existing research data and clinical observations.
  • Analysis of patient data regarding HDV infection stages and liver disease presence.

Related Experiment Videos

  • Consideration of the interplay between HBV and HDV.

    • Main Results:

    • Data suggest HDV can be directly cytopathic or non-cytopathic, varying with infection stage.
    • While most HDV-infected patients have liver disease, healthy carriers exist, particularly with low HBV replication.
    • Different HDV strains may correlate with varied disease outcomes.

    Conclusions:

    • HDV's pathogenicity is complex and stage-dependent.
    • The interaction between HBV and HDV is crucial and warrants further investigation.
    • Understanding these interactions is key to predicting HDV disease progression and outcomes.